Results for tag: "Amrubicin"

Amrubicin is an oncology drug used to treat a variety of cancers, including non-small cell lung cancer, small cell lung cancer, and ovarian cancer. It is a type of anthracycline, a class of chemotherapy drugs that work by interfering with the growth of cancer cells. Amrubicin is administered intravenously and is typically used in combination with other drugs. It is generally well-tolerated, but can cause side effects such as nausea, vomiting, and hair loss. Amrubicin is approved for use in several countries, including the United States, Japan, and the European Union. It is marketed by several pharmaceutical companies, including Eisai, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more